Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Pfizer Inc. (PFE)

Pfizer Extends Vyndamax Patent Protection To 2031 After Settlements With Generics 4/28/2026 10:21:24 AM

Pfizer Declares Q2 Dividend Of $0.43/share, Payable June 12/ Record May 8 4/22/2026 4:57:41 PM

Merck: FDA Grants Priority Review For SBLAs For KEYTRUDA, KEYTRUDA QLEX, Each With Padcev 4/20/2026 7:13:10 AM

Astellas Pharma And Pfizer: FDA Grants Priority Review To SBLA For PADCEV + Keytruda 4/20/2026 7:01:59 AM

GSK Announces Completion Of Pfizer's Exit Of Its Investment In ViiV Healthcare 4/1/2026 2:35:40 AM

GSK, Pfizer And Shionogi Complete Changes To ViiV Healthcare Shareholding 4/1/2026 2:07:06 AM

Pfizer: Lyme Disease Vaccine Candidate Shows Strong Efficacy In Phase 3 VALOR Trial 3/23/2026 7:46:13 AM

Pfizer And Valneva's Lyme Disease Vaccine Candidate Demonstrates Over 70% Efficacy In Phase 3 Trial 3/23/2026 6:51:17 AM

Pfizer Reports Positive Results From Phase 3 TALAPRO-3 Study In Metastatic Prostate Cancer 3/19/2026 7:48:31 AM

Pfizer Reports Positive Topline Results From Phase 3 TALAPRO-3 Study In Metastatic Castration-Sensitive Prostate Cancer 3/19/2026 7:00:06 AM

Pfizer's Atirmociclib Meets Primary Endpoint In Phase 2 FOURLIGHT-1 Breast Cancer Trial 3/17/2026 7:28:00 AM

Pfizer Announces Positive Topline Results From Phase 2 FOURLIGHT-1 Study Of Atirmociclib With Fulvestrant 3/17/2026 6:57:15 AM

Weekly Buzz: BMY Wins FDA Nod; EU Okays JNJ's AKEEGA; IPSEY Withdraws Tazverik, DAWN Acquired 3/13/2026 10:14:13 AM

Pfizer: Tilrekimig Antibody Phase 2 Study Meets Primary Goal In Moderate To Severe Atopic Dermatitis 3/9/2026 7:47:02 AM

Pfizer Announces Positive Topline Results From Phase 2 Study Of Tilrekimig In Moderate To Severe Atopic Dermatitis 3/9/2026 6:48:41 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap